tabletki o przedłużonym uwalnianiu clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
Early ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
This study looks at treating an irregular heartbeat called atrial fibrillation (AF) early in people with a heart condition called hypertrophic cardiomyopathy (HCM). It's trying to find out if early treatment of AF helps prevent serious health issues like stroke or further heart problems.
For: Hypertrophic cardiomyopathy (HCM) is the most common genetically determined disease of the heart · characterized by a varied picture and clinical course. The first comprehensive clinical description of the disease comes from the 1960s. Currently · the disease is diagnosed on the basis of a phenotypic picture showing left ventricular hypertrophyPoland - Ongoing, recruitingTherapeutic confirmatory (Phase III)
The efficacy and safety of Metoprolol as add-on treatment to standard of care in preventing cardiomyopathy in patients with Duchenne Muscular Dystrophy aged 8-17 years. A randomized, double-blind, placebo controlled study
This study looks at whether a medicine called Metoprolol can help prevent heart problems in young people with Duchenne Muscular Dystrophy. It compares Metoprolol to a dummy medicine to see if it makes a difference to heart strength.
For: Duchenne muscular dystrophy · Cardiomyopathy · TachycardiaPoland - Ongoing, recruitingHuman Pharmacology (Phase I)- Other
A PHASE 1, OPENLABEL, SINGLECENTER STUDY TO EVALUATE DRUGDRUG INTERACTIONS WITH GEMFIBROZIL, ITRACONAZOLE, AND CARBAMAZEPINE AND THE FOOD-EFFECT ON ORAL LERIGLITAZONE IN MALE HEALTHY SUBJECTS
This study is looking at how a new drug, leriglitazone, behaves in the body of healthy men. It checks if other common medicines or food affect how leriglitazone works. This helps us understand its safety and effectiveness for conditions like Adrenoleukodystrophy.
For: AdrenoleukodystrophyPoland